Zobrazeno 1 - 10
of 197
pro vyhledávání: '"Luis Masana"'
Autor:
Anna Pàmies, Dídac Llop, Daiana Ibarretxe, Roser Rosales, Luis Masana, Joan-Carles Vallvé, Silvia Paredes
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 1680-1688 (2024)
Introduction: Patients with RA are at a higher risk of developing CV diseases than the general population. The precise mechanisms are still unknown. We evaluated the associations between 8 plasma growth factors (GFs) (angiopoietin-2, EGF, HB-EGF, PLG
Externí odkaz:
https://doaj.org/article/6b91429ebe334b9c9f0ff807a62b85b1
Autor:
Delia Taverner, Dídac Llop, Roser Rosales, Raimon Ferré, Luis Masana, Joan-Carles Vallvé, Silvia Paredes
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract To validate in a cohort of 214 rheumatoid arthritis patients a panel of 10 plasmatic microRNAs, which we previously identified and that can facilitate earlier diagnosis of cardiovascular disease in rheumatoid arthritis patients. We identifie
Externí odkaz:
https://doaj.org/article/e75ea565a96141f5807853714d625cb2
Autor:
Josep Gumà, Jose Adriá-Cebrián, Belen Ruiz-Aguado, Cinta Albacar, Josefa Girona, Ricardo Rodríguez-Calvo, Neus Martínez-Micaelo, Eric W. F. Lam, Luis Masana, Sandra Guaita-Esteruelas
Publikováno v:
Cancers, Vol 13, Iss 17, p 4281 (2021)
Background: Altered lipid metabolism has been described in some types of cancer. To analyse in depth the metabolic modifications in breast cancer patients, advanced 1H-nuclear magnetic resonance was performed in these patients. The main objective of
Externí odkaz:
https://doaj.org/article/9ce5db7a23e44696a45aafc0680dab9a
Publikováno v:
PPAR Research, Vol 2015 (2015)
Here we studied the impact of 5-aminoimidazole-4-carboxamide riboside (AICAR), a well-known AMPK activator, on cardiac metabolic adaptation. AMPK activation by AICAR was confirmed by increased phospho-Thr172-AMPK and phospho-Ser79-ACC protein levels
Externí odkaz:
https://doaj.org/article/ebf9e2f69fb34a3da7eb9fed4a19b65d
Autor:
Cèlia Rodríguez-Borjabad, Ingunn Narveud, Jacob Juel Christensen, Daiana Ibarretxe, Natalia Andreychuk, Josefa Girona, Kristin Torvik, Guro Folkedal, Martin P. Bogsrud, Kjetil Retterstøl, Núria Plana, Luis Masana, Kirsten B. Holven
Publikováno v:
Atherosclerosis. 373:38-45
Autor:
Marina Cuchel, Frederick J Raal, Robert A Hegele, Khalid Al-Rasadi, Marcello Arca, Maurizio Averna, Eric Bruckert, Tomas Freiberger, Daniel Gaudet, Mariko Harada-Shiba, Lisa C Hudgins, Meral Kayikcioglu, Luis Masana, Klaus G Parhofer, Jeanine E Roeters van Lennep, Raul D Santos, Erik S G Stroes, Gerald F Watts, Albert Wiegman, Jane K Stock, Lale S Tokgözoğlu, Alberico L Catapano, Kausik K Ray
Publikováno v:
European Heart Journal.
This 2023 statement updates clinical guidance for homozygous familial hypercholesterolaemia (HoFH), explains the genetic complexity, and provides pragmatic recommendations to address inequities in HoFH care worldwide. Key strengths include updated cr
Autor:
Luis Masana, Daiana Ibarretxe, Natalia Andreychuk, Meritxell Royuela, Celia Rodríguez-Borjabad, Nuria Plana
Publikováno v:
European Atherosclerosis Journal. 1:25-29
The causal role of cholesterol in atherosclerosis was established more than 100 years ago. Along with the fact that the higher the cholesterol, the greater the risk of atherosclerotic cardiovascular diseases (ASCVD), many randomized controlled trials
Autor:
Dirk J. Blom, Daniel Gaudet, Robert A. Hegele, Dharmesh S. Patel, Jaimini Cegla, Genovefa Kolovou, Luis Masana Marin
Publikováno v:
Advances in Therapy. 39:1857-1870
Autor:
José R. González-Juanatey, Alberto Cordero, José Mª. Castellano, Luis Masana, Regina Dalmau, Emilio Ruiz, Antonio Sicras-Mainar, Valentín Fuster
To evaluate the effectiveness of a cardiovascular polypill including aspirin, ramipril and atorvastatin (CNIC-Polypill), on the incidence of recurrent major cardiovascular events (MACE) and risk factor control in patients with established atheroscler
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26434d24570b7146c3fce499ec1599e3
https://hdl.handle.net/20.500.12105/15650
https://hdl.handle.net/20.500.12105/15650
Autor:
Anabel Martín-Urda, Joan García-Vilches, Núria Plana, Cèlia Rodríguez-Borjabad, Daiana Ibarretxe, Alberto Zamora, Luis Masana, Oriol Alonso Gisbert, Ana Inés Méndez Martínez, Guillem Paluzie
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 33:138-147
Familial Hypercholesterolemia (FH) is an autosomal dominant disease with an estimated prevalence between 1/200-250. It is under-treated and underdiagnosed. Massive data screening can increase the detection of patients with FH.Study population: Reside